BVF Inc’s Kezar Life Sciences KZR Stock Holding History

BVF Inc’s Portfolio KZR Stock Details KZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-156,437	Closed	-$6.82M	–	61
2020 Q1	$6.82M	Buy	156,437 +144,766	+1,240%	+$5.89M	0.64%	32
2019 Q4	$468K	Buy	+11,671	New	+$359K	0.04%	57

Other funds holding KZR

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

BVF Inc's KZR Position: Q2 2020 in Review

BVF Inc sold out of Kezar Life Sciences (KZR) in Q2 2020, closing a stake of 156,437 shares — an estimated $6.82M sold.

BVF Inc first reported a position in KZR in Q4 2019 and held it in 2 quarters. The position peaked at $6.82M in Q1 2020. 85 funds tracked by Wall St. Rank hold KZR as of Q2 2020.

BVF Inc reported no remaining Kezar Life Sciences position as of Q2 2020 after selling out during the quarter.
BVF Inc sold 156,437 Kezar Life Sciences shares in Q2 2020, an estimated $6.82M.
BVF Inc first reported a position in Kezar Life Sciences in Q4 2019 and held it in 2 quarters.
BVF Inc's Kezar Life Sciences position peaked at $6.82M in Q1 2020.
85 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2020.

Based on BVF Inc's 13F filing for Q2 2020, filed 14 Aug 2020.